
Randomized clinical trial of omega‐3 fatty acid‐supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery
Author(s) -
Sultan J.,
Griffin S. M.,
Di Franco F.,
Kirby J. A.,
Shenton B. K.,
Seal C. J.,
Davis P.,
Viswanath Y. K. S.,
Preston S. R.,
Hayes N.
Publication year - 2012
Publication title -
british journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.202
H-Index - 201
eISSN - 1365-2168
pISSN - 0007-1323
DOI - 10.1002/bjs.7799
Subject(s) - medicine , enteral administration , gastroenterology , perioperative , parenteral nutrition , randomized controlled trial , cancer , fatty acid , clinical trial , surgery , chemistry , organic chemistry
Oesophagogastric cancer surgery is immunosuppressive. This may be modulated by omega-3 fatty acids (O-3FAs). The aim of this study was to assess the effect of perioperative O-3FAs on clinical outcome and immune function after oesophagogastric cancer surgery.